查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球梅毒检测市场 2023-2030
市场调查报告书
商品编码
1327637

全球梅毒检测市场 2023-2030

Global Syphilis Testing Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 75 Pages | 商品交期: 2-3个工作天内

价格

预计全球梅毒检测市场在预测期内（2023-2030）将以 6.2% 的复合年增长率增长。钯密螺旋体是引起性传播疾病梅毒的细菌。在前两个阶段，它的传染性最强。梅毒的初始阶段是隐性或潜伏阶段，在​​此期间患者不会受到伤害。虽然没有任何症状，但疾病仍然存在。该疾病的第二阶段，称为三期梅毒，对健康危害最大。加速市场发展的一些主要驱动因素包括性传播感染（STD）患病率的上升、流产的增加以及医疗保健行业对高效疾病诊断和测试解决方案的需求不断增长。因此，市场参与者在创建梅毒检测产品和配套服务组合时将重点放在技术开发上，这将进一步支持市场扩张。例如，2023 年 2 月，为了应对大学校园性传播感染的兴起，Caraway 和 Ash Wellness 建立了合作伙伴关係。试剂盒中包含性传播感染 (STI) 和性传播感染 (STI) 检测，例如衣原体、淋病、梅毒、艾滋病毒、丙型肝炎、滴虫病、念珠菌病和细菌性阴道病。

细分市场前景

全球梅毒检测市场根据检测类型、地点、技术和最终用户进行细分。根据类型，市场分为一期和二期梅毒以及潜伏和三期梅毒。根据检测地点，市场可细分为实验室检测和即时护理 (POC) 检测。此外，根据技术，市场细分为 CLIA、ELISA、NAAT 等。按最终用户划分，市场分为医院、诊断实验室和家庭护理。

预计实验室检测细分市场将在全球梅毒检测市场中占据相当大的份额

在检测地点中，实验室检测细分市场预计将在全球梅毒检测市场中占据相当大的份额。部分增长归因于多种血清学检测、快速血浆恢復（RPR）检测和梅毒螺旋体颗粒凝集（TPPA）检测的影响力不断增强，以及实验室检测技术的进步和自动化系统的可用性提高了效率和周转时间梅毒检测时间。政府和医疗保健组织的医疗保健活动、教育计划以及倡议都强调了梅毒检测的重要性。根据美国国立卫生研究院 (NIH) 的说法，在活动性梅毒的情况下，非梅毒螺旋体检测通常会呈阳性，并且会进行滴度测试。当后续血清学检测显示 VDRL 或 RPR 滴度呈阳性时，表明梅毒处于活动状态，可用于跟踪治疗效果。例如，2023 年2 月，妇幼保健公司Maternova 与MedMira 建立了分销合作伙伴关係，MedMira 是艾滋病毒、肝炎、梅毒等性传播感染疾病快速诊断测试的创造者和製造商，总部位于加拿大新斯科舍省。

区域展望

全球梅毒检测市场根据地理位置进一步细分，包括北美（美国和加拿大）、欧洲（英国、意大利、西班牙、德国、法国和欧洲其他地区）、亚太地区（印度、中国、日本） 、韩国和亚洲其他地区）以及世界其他地区（中东和非洲以及拉丁美洲）。其中，亚太地区预计将在全球市场中占据显着份额，因为不断增长的医疗保健行业以及高效医疗保健基础设施的建立。

北美地区预计全球梅毒检测市场复合年增长率显着增长

在所有地区中，预计北美在预测期内将以相当大的复合年增长率增长。北美，特别是美国，将继续发挥不可忽视的关键作用。区域增长归因于现代技术的广泛使用以及该地区主要竞争对手的存在，这为市场参与者提供了多种扩张机会。例如，2023 年3 月，加拿大卫生部最近批准了一种HIV-梅毒双重快速检测，经过两年的临床试验表明，该检测在检测HIV 感染方面的准确度为100%，在检测活动性梅毒方面的准确度为98%。 DPP HIV-梅毒系统使性传播疾病的快速检测取得了令人兴奋的进展。 DPP HIV-梅毒系统目前可供美国超过 200,000 个 CLIA 豁免的即时检测机构使用。推动市场增长的另一个因素是MSM（男男性行为）病例的增加以及对孕妇进行筛查测试的要求。

市场参与者展望

服务于梅毒检测市场的主要公司包括： Abbott 实验室、Bio-Rad 实验室公司、F. Hoffmann-La Roche AG、Thermo Fisher Scientific Inc.、Hologoic Inc. 等。通过使用各种技术，包括併购、伙伴关係、合作、融资和新产品的推出，该行业的公司正在显着促进市场增长。例如，2023 年 3 月，加拿大卫生部授权 bioLytical Laboratory Inc. 进行 INSTI (R) Multiplex HIV-1/2 梅毒抗体检测。该测试通过仅使用一份样本提供两种感染的结果，使医生能够在更短的时间内测试更多的人，从而减轻患者的测试焦虑。

报告涵盖：

  • 2022年市场价值数据分析及2030年预测。
  • 每个细分市场的年化市场收入（百万美元）。
  • 主要地理区域的国家分析。
  • 全球梅毒检测市场的主要公司。根据现有数据，报告中还提供了与新产品发布相关的信息以及相关新闻。
  • 通过确定未来强劲增长的关键细分市场来分析业务战略。
  • 市场进入和市场扩张策略分析。
  • 通过识别市场中“谁的立场”来製定竞争策略。

目录

第 1 章：报告摘要

  • 当前行业分析及增长潜力展望
  • 研究方法和工具
  • 市场细分
    • 按细分
    • 按地区

第 2 章：市场概述和见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • Abbott Laboratories
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Becton Dickinson and Co.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Bio-Rad Laboratories Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 按类型分類的全球梅毒检测市场
    • 一期和二期梅毒
    • 潜伏梅毒和三期梅毒
  • 按检测地点分類的全球梅毒检测市场
    • 实验室测试
    • 即时护理 (POC) 测试
  • 按技术分類的全球梅毒检测市场
    • 临床实验室改进修正案 (CLIA)
    • 酶联免疫吸附测定 (ELISA)
    • 核酸扩增测试（NAAT）
    • 其他的
  • 按最终用户分類的全球梅毒检测市场
    • 医院
    • 诊断测试
    • 家庭护理

第 5 章：区域分析

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 意大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • Astam Dignostic
  • Beckman Coulter
  • bioLytical laboratories Inc.
  • BioMerieux SA
  • Cepheid Inc.
  • Danaher corp.
  • Diasorin S.P.A
  • DRG International Inc. (BioCheck Inc.)
  • F. Hoffmann-La Roche AG
  • Fujirebio
  • Hologoic Inc
  • Omega diagnostics Group PLC
  • Shenzhen new industries Biomedical Engineering Co., Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
Product Code: OMR2027544

Title: Global Syphilis Testing Market Size, Share & Trends Analysis Report by Type (Primary and Secondary Syphilis, Latent and Tertiary Syphilis), by Location of Testing (Laboratory Testing, Point-of-Care (POC) Testing), and by Technology (Clinical Laboratory Improvement Amendments (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Nucleic Acid Amplification Test (NAAT), and Others), by End User (Hospitals, Diagnostic Labs, Home Care),Forecast Period (2023-2030).

The global syphilis testing market is anticipated to grow at a CAGR of 6.2% during the forecast period (2023-2030). Treponema palladium is the bacterium that causes the sexually transmitted disease syphilis. During the first two phases, it is most contagious. The initial stage of syphilis is the concealed, or latent, stage, during which the patient is not harmed. Although there are no symptoms, the disease is still vital. The second stage of the disease, referred to as tertiary syphilis, is the most harmful to health. Some main driving factor that accelerating the market include the rising prevalence of sexually transmitted infections (STDs), the rise in miscarriages, and the rising demand for efficient disease diagnostic and testing solutions in the healthcare industry. As a result, market participants are concentrating on technology developments when creating syphilis testing products and accompanying service portfolios, which will further support market expansion. For Instance, In February 2023, to combat the rise of STIs on college campuses, Caraway and Ash Wellness started a partnership. tests for STIs and sexually transmitted infections (STIs), such as chlamydia, gonorrhea, syphilis, HIV, hepatitis C, trichomoniasis, candidiasis, and bacterial vaginosis, are included in the kits.

Segmental Outlook

The global syphilis testing market is segmented on the type, location of testing, technology, and end-users. Based on the type, the market is sub-segmented into primary & secondary syphilis and latent & tertiary syphilis. Based on the location of testing, the market is sub-segmented laboratory testing and point-of-care (POC) testing. Further, on the basis of technology, the market is sub-segmented into CLIA, ELISA, NAATs, and others. By end-user, the market is sub-segmented into hospitals, diagnostic labs, and home care.

The Laboratory Testing Sub-Segment is Anticipated to Hold a Considerable Share of the Global Syphilis Testing Market

Among the location of testing, the laboratory testing sub-segment is expected to hold a considerable share of the global syphilis testing market. The segmental growth is attributed to the growing influence of several serological tests, rapid plasma regain (RPR) test, and Treponema pallidum particle agglutination (TPPA) test, and advancements in laboratory testing technologies and the availability of automated systems have improved the efficiency and turnaround time of syphilis testing. Healthcare campaigns, educational programs, and initiatives by governments and healthcare organizations have emphasized the significance of syphilis testing. According to the National Institute of Health (NIH), The nontreponemal test will typically be positive in situations of active syphilis, and a titter will be carried out. When a follow-up serologic test reveals a positive titter with a VDRL or RPR, it indicates that syphilis is active, and it is used to track treatment effectiveness. For instance, in February 2023, the maternal and child health company Maternova established a distribution partnership with MedMira, a creator and manufacturer of quick diagnostic tests for STIs diseases like HIV, hepatitis, syphilis, and others with headquarters in Nova Scotia, Canada.

Regional Outlook

The global syphilis testing market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, the Asia-Pacific region is anticipated to hold a prominent share of the market across the globe, owing to the continuously growing healthcare industry coupled with rise in establishment of efficient healthcare infrastructure.

The North America Region is Expected to Grow at a Significant CAGR in the Global Syphilis Testing Market

Among all regions, North America is anticipated to grow at a considerable CAGR over the forecast period. North America, and particularly the US, will continue to play a crucial role that cannot be disregarded. The regional growth is attributed to the widespread use of modern technologies and the presence of major competitors in the region, which offers several opportunities of expansion for market players. For instance, in March 2023, a dual HIV-syphilis fast test was recently approved by Health Canada after a two-year clinical trial revealed that it was 100% accurate at detecting HIV infections and 98% accurate in detecting active syphilis. Rapid testing for sexually transmitted illnesses has excitingly advanced with the DPP HIV-Syphilis System. The DPP HIV-Syphilis System is currently available to more than 200,000 CLIA-waived point-of-care testing facilities in the US. Another factor bolstering the market growth is owing to the rising MSM (men having sex with men) cases along with the implementation of screening tests as a requirement for pregnant women.

Market Players Outlook

The major companies serving the syphilis testing market include: Abbott laboratories, Bio-Rad laboratories Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Hologoic Inc. and others. By using a variety of techniques, including as mergers and acquisitions, partnerships, collaborations, funding, and the launch of new products, companies in the industry are significantly boosting market growth. For instance, in March 2023 Health Canada grants authorization to bioLytical laboratories Inc. for its INSTI® Multiplex HIV-1/2 syphilis antibody test. The test lessens test anxiety for patients by enabling medical practitioners to test more people in less time by providing results for two infections with just one sample.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global syphilis testing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Abbott Laboratories
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Becton Dickinson and Co.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Bio-Rad Laboratories Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Syphilis Testing Market by Type
    • 4.1.1. Primary and secondary Syphilis
    • 4.1.2. Latent and Tertiary Syphilis
  • 4.2. Global Syphilis Testing Market by Location of Testing
    • 4.2.1. Laboratory Testing
    • 4.2.2. Point-of-Care (POC) Testing
  • 4.3. Global Syphilis Testing Market by Technology
    • 4.3.1. Clinical Laboratory Improvement Amendments (CLIA)
    • 4.3.2. Enzyme-Linked Immunosorbent Assay (ELISA)
    • 4.3.3. Nucleic Acid Amplification Test (NAAT)
    • 4.3.4. Others
  • 4.4. Global Syphilis Testing Market by End User
    • 4.4.1. Hospitals
    • 4.4.2. Diagnostic Test
    • 4.4.3. Home Care

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Astam Dignostic
  • 6.2. Beckman Coulter
  • 6.3. bioLytical laboratories Inc.
  • 6.4. BioMerieux SA
  • 6.5. Cepheid Inc.
  • 6.6. Danaher corp.
  • 6.7. Diasorin S.P.A
  • 6.8. DRG International Inc. (BioCheck Inc.)
  • 6.9. F. Hoffmann-La Roche AG
  • 6.10. Fujirebio
  • 6.11. Hologoic Inc
  • 6.12. Omega diagnostics Group PLC
  • 6.13. Shenzhen new industries Biomedical Engineering Co., Ltd.
  • 6.14. Siemens Healthineers AG
  • 6.15. Thermo Fisher Scientific Inc.

LIST OF TABLES

  • 1. GLOBAL SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL PRIMARY AND SECONDARY SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL LATENT AND TERTIARY SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2022-2030 ($ MILLION)
  • 5. GLOBAL SYPHILIS TESTING IN LABORATORY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL SYPHILIS TESTING IN POINT-OF-CARE (POC) MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 8. GLOBAL CLIA-BASED SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 9. GLOBAL ELISA-BASED SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 10. GLOBAL NAATS-BASED SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 11. GLOBAL OTHER TECHNOLOGIES BASED SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 12. GLOBAL SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 13. GLOBAL SYPHILIS TESTING IN HOSPITALS MARKET RESEARCH AND ANALYSIS 2022-2030 ($ MILLION)
  • 14. GLOBAL SYPHILIS TESTING IN DIAGNOSTIC LABS MARKET RESEARCH AND ANALYSIS 2022-2030 ($ MILLION)
  • 15. GLOBAL SYPHILIS TESTING IN HOME-CARE MARKET RESEARCH AND ANALYSIS 2022-2030 ($ MILLION)
  • 16. GLOBAL SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 19. NORTH AMERICAN SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2022-2030 ($ MILLION)
  • 20. NORTH AMERICAN SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 21. NORTH AMERICAN SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 22. NORTH AMERICAN SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. EUROPE SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 24. EUROPE SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2022-2030 ($ MILLION)
  • 25. EUROPE SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 26. EUROPE SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 27. ASIA-PACIFIC SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TYPE 2022-2030 ($ MILLION)
  • 28. ASIA-PACIFIC SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2022-2030 ($ MILLION)
  • 29. ASIA-PACIFIC SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 30. ASIA-PACIFIC SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 31. REST OF THE WORLD SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 32. REST OF THE WORLD SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2022-2030 ($ MILLION)
  • 33. REST OF THE WORLD SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 34. REST OF THE WORLD SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL SYPHILIS TESTING MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL PRIMARY AND SECONDARY SYPHILIS TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL LATENT AND TERTIARY SYPHILIS TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2022 VS 2030 (%)
  • 5. GLOBAL SYPHILIS TESTING IN LABORATORY MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL SYPHILIS TESTING IN POINT-OF-CARE (POC)MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022 VS 2030 (%)
  • 8. GLOBAL CLIA-BASED SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022 VS 2030 (%)
  • 9. GLOBAL ELISA-BASED SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022 VS 2030 (%)
  • 10. GLOBAL NAATS-BASED SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022 VS 2030 (%)
  • 11. GLOBAL OTHER TECHNOLOGIES BASED SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022 VS 2030 (%)
  • 12. GLOBAL SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022 VS 2030 (%)
  • 13. GLOBAL SYPHILIS TESTING IN HOSPITALS MARKET RESEARCH AND ANALYSIS, 2022 VS 2030 (%)
  • 14. GLOBAL SYPHILIS TESTING IN DIAGNOSTIC LABS MARKET RESEARCH AND ANALYSIS, 2022 VS 2030 (%)
  • 15. GLOBAL SYPHILIS TESTING IN HOME-CARE MARKET RESEARCH AND ANALYSIS, 2022 VS 2030 (%)
  • 16. GLOBAL SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 17. GLOBAL SYPHILIS TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 18. US SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. CANADA SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. UK SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. FRANCE SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. GERMANY SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. ITALY SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. SPAIN SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. REST OF EUROPE SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. INDIA SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. CHINA SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. JAPAN SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. SOUTH KOREA SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. REST OF ASIA-PACIFIC SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 31. REST OF THE WORLD SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)